InvestSMART

Ellex Medical Lasers Limited (ASX: ELX) - Announcements

Current share price for ELX : $0.710 0.025 (3.65%)+

ASX company news and announcements for Ellex Medical Lasers Limited (ELX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Ellex Medical Lasers Limited (ELX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Ellex Medical Lasers Limited (ELX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Ellex Medical Lasers Limited (ELX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$102 Annual Report to shareholders 29 Sep 2015 6:43PM $0.395 $0.710 risen by 79.75%
$102 Ellex releases first case study results for 2RT at tradeshow 14 Sep 2015 10:33AM $0.375 $0.710 risen by 89.33%
$102 ELX Investor Presentation FY15 Results 27 Aug 2015 10:50AM $0.345 $0.710 risen by 105.80%
$102 Ellex Report Full Year 2015 Preliminary Report Appendix 4E 27 Aug 2015 10:50AM $0.345 $0.710 risen by 105.80%
$102 ELX Preliminary Financial Report Appendix 4E FY15 27 Aug 2015 10:50AM $0.345 $0.710 risen by 105.80%
$102 Trading Update for the Full Year Ended 30 June 2015 30 Jul 2015 9:27AM $0.290 $0.710 risen by 144.83%
$102 2RT Grant Awarded, Commercial Update 14 Jul 2015 10:53AM $0.310 $0.710 risen by 129.03%
$102 More Scientific Research Validates Clinical Effect of 2RT 19 May 2015 9:34AM $0.340 $0.710 risen by 108.82%
$102 Ellex lifts Global Market Share 6 May 2015 10:00AM $0.340 $0.710 risen by 108.82%
$102 Half Yearly Report and Accounts 27 Feb 2015 9:39AM $0.320 $0.710 risen by 121.88%
$102 Trading Update for the half-year ended 31 December 2014 29 Jan 2015 9:53AM n/a $0.710 n/a
$102 Shareholder Update at AGM 26 Nov 2014 1:31PM $0.320 $0.710 risen by 121.88%
$102 Further positive clinical data on 2RT 18 Nov 2014 10:09AM $0.315 $0.710 risen by 125.40%
$102 Appendix 4E & Full-Year Statutory Accounts 29 Aug 2014 9:20AM $0.350 $0.710 risen by 102.86%
$102 Trading Update FY14 Results 5 Aug 2014 9:48AM $0.350 $0.710 risen by 102.86%
$102 Commercial Sales of 2RT Laser 8 Jul 2014 10:17AM $0.350 $0.710 risen by 102.86%
$102 ELX announces further results for 2RT treatment of early AMD 15 May 2014 11:34AM $0.320 $0.710 risen by 121.88%
$102 Half Yearly Report and Accounts 27 Feb 2014 11:37AM $0.400 $0.710 risen by 77.50%
$102 Ellex - CE Mark for 2RT Treatment of Early Stage AMD 24 Feb 2014 10:14AM $0.390 $0.710 risen by 82.05%
$102 Trading Update for half-year ended 31 December 2013 30 Jan 2014 11:19AM $0.440 $0.710 risen by 61.36%
$102 Acquistion and Capital Raise 20 Dec 2013 9:52AM $0.320 $0.710 risen by 121.88%
$102 Trading Halt 18 Dec 2013 9:23AM $0.320 $0.710 risen by 121.88%
$102 ELX USA SLT Glaucoma Laser Update 12 Nov 2013 9:04AM $0.330 $0.710 risen by 115.15%
$102 Release of Positive Pilot Study Results for 2RT Treatment 14 Oct 2013 9:50AM $0.305 $0.710 risen by 132.79%
$102 Ellex Secures US Government Qualification for SLT Lasers 26 Sep 2013 3:14PM $0.310 $0.710 risen by 129.03%

201 - 225 of 310 results

Page 9 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.